Author: Advanced Medical Reviews

Third-Party Reviewers: Offering Streamlined Solutions for Payment Integrity

Unfortunately, the healthcare industry faces challenges with financial waste. It has been estimated that the healthcare system in the United States wastes approximately $765 billion annually, about 25 percent of what is spent. Part of this number is due to payment integrity issues such as fraud, waste and abuse (FWA). If you’re not familiar with […]

Summer 2019: Healthcare Updates to Know

Each season brings new changes and modifications to the healthcare industry. With summer here, we’ve highlighted important issues, healthcare coverage changes and advances in medical research. Cybersecurity Still Troubles the Industry The healthcare industry continues to be plagued by cybersecurity issues. A newly published 2019 Data Breach Investigations Report from Verizon found that of the […]

How Healthcare Organizations Can Tackle Social Determinants of Health

There’s no way around it–healthcare in the United States is expensive. This country spends about twice as much per person compared to other developed nations. One key way healthcare organizations are addressing these issues is factoring in social determinants of health (SDOH). The World Health Organization defines SDOH as “the conditions in which people are […]

Bringing Telehealth to the Rehabilitation Industry

The future of telehealth continues to build interest due to its convenience and cost-effectiveness. Not only does it increase access to care and reduce travel time—especially for people living in rural areas—but telehealth also decreases the number of hospital stays and can improve communication between clinicians. According to the American Hospital Association (AHA), 76 percent […]

Spring 2019: Healthcare Updates to Know

A new season has arrived, and it brings new changes within the healthcare industry. To help keep you informed about these issues and how they may affect you, we’ve compiled the most important industry news. FDA Commissioner Resigns Dr. Scott Gottlieb, the 23rd commissioner of the United States Food and Drug Administration, recently resigned after […]

Next Page » « Previous Page